The findings also linked KRT15 and KRT19 expression to the basal and LumA PCa subtypes and further demonstrated that high expression of KRT15 and KRT19 was associated with increased risk of biochemical recurrence and reduced overall survival. Here, KRT15 is linked to posterior cortical atrophy.